Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon

Author(s):
Evers, M.M.; Tran, H.D.; Zalachoras, I.; Pepers, B.A.; Meijer, O.C. (0000-0002-8394-6859); Dunnen, J.T. den (0000-0002-6304-1710); Ommen, G.J.B. van; Aartsma-Rus, A.; Roon-Mom, W.M.C. van
Published
2013
Publication type
Article / Letter to editor
Spinocerebellar ataxia type 3Polyglutamine disorderAtaxin-3Exon skippingCAG repeatPolyglutamine repeat
Date issued
2013-10-31
Language
English
Is part of
Neurobiology of Disease (2013), Vol. 58, p. 49-56
hdl
1887/102108
doi
10.1016/j.nbd.2013.04.019